MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration

PURPOSE: Currently, no outcome measures are clinically validated and accepted as clinical endpoints by regulatory agencies for drug development in intermediate age-related macular degeneration (iAMD). The MACUSTAR Consortium, a public-private research group funded by the European Innovative Medicine...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ophthalmologica
Egile Nagusiak: Finger, Robert P., Schmitz-Valckenberg, Steffen, Schmid, Matthias, Rubin, Gary S., Dunbar, Hannah, Tufail, Adnan, Crabb, David P., Binns, Alison, Sánchez, Clara I., Margaron, Philippe, Normand, Guillaume, Durbin, Mary K., Luhmann, Ulrich F.O., Zamiri, Parisa, Cunha-Vaz, José, Asmus, Friedrich, Holz, Frank G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger AG 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482983/
https://ncbi.nlm.nih.gov/pubmed/30153664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491402
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak